Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Granulocyte colony-stimulating factor

I A Tabbara1

  • 1Bone Marrow Transplant Program, George Washington University School of Medicine, Washington, DC.

Southern Medical Journal
|March 1, 1993
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Advanced germ cell tumors in male patients.

Southern medical journal·2000
Same author

Empiric antimicrobial therapy of febrile neutropenic patients undergoing haematopoietic stem cell transplantation.

International journal of antimicrobial agents·1999
Same author

Ceftazidime and ciprofloxacin as empiric therapy in febrile neutropenic patients undergoing hematopoietic stem cell transplantation.

Clinical therapeutics·1997
Same author

The role of granulocyte colony-stimulating factor in hematopoietic stem cell transplantation.

Cancer investigation·1997
Same author

The clinical applications of granulocyte colony-stimulating factor in hematopoietic stem cell transplantation: a review.

Anticancer research·1996
Same author

Allogeneic bone marrow transplantation.

Southern medical journal·1996

Recombinant human granulocyte colony-stimulating factor (G-CSF) stimulates neutrophil production and function. This protein therapy effectively reduces neutropenia, aids recovery after bone marrow transplantation, and mobilizes stem cells, with mild side effects.

Area of Science:

  • Hematology
  • Immunology
  • Biotechnology

Background:

  • Granulocyte colony-stimulating factor (G-CSF) is a protein that stimulates granulocyte production.
  • Recombinant G-CSF is produced using recombinant DNA technology in Escherichia coli.
  • G-CSF influences both primitive stem cells and differentiated myeloid cells.

Purpose of the Study:

  • To review the effects and clinical applications of recombinant human G-CSF.
  • To highlight G-CSF's role in managing neutropenia and enhancing immune cell function.
  • To discuss G-CSF's utility in bone marrow transplantation and stem cell mobilization.

Main Methods:

  • Review of in vitro studies defining G-CSF's effects on myeloid cell colonies and differentiation.
  • Analysis of clinical trial data on G-CSF's efficacy in various neutropenic conditions.

Related Experiment Videos

  • Evaluation of G-CSF's impact on neutrophil and monocyte functions, including phagocytosis and cytotoxicity.

    • Main Results:

    • G-CSF stimulates granulocyte colony formation and induces differentiation of leukemic cell lines.
    • Clinical studies demonstrate G-CSF reduces neutropenia duration, febrile episodes, and hospitalization post-chemotherapy.
    • G-CSF accelerates neutrophil recovery after bone marrow transplantation and mobilizes peripheral blood stem cells.

    Conclusions:

    • Recombinant human G-CSF is a valuable therapeutic agent for neutropenia and related conditions.
    • G-CSF enhances neutrophil function and is well-tolerated, with bone pain as the main side effect.
    • Ongoing trials are expected to expand the clinical applications of G-CSF.